Inhaled corticosteroids, family history, and risk of glaucoma

Ophthalmology

Volumn 106, Issue 12, 1999, Pages 2301-2306

  Mitchell, Paul ^a,d   Cumming, Robert G ^a   Mackey, David A ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FAMILY HISTORY; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0033498223     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90530-4     Document Type: Article

References (34)

1. Francois J. Cortisone et tension oculaire. Ann Ocul Par 1954; 187:805-16.
2. Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. JAMA 1963;185:884-6.
3. Steroid glaucoma. Br Med J 1965;5474:1324.
4. Williamson J, Paterson RW, McGavin DD, et al. Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy in patients with rheumatoid arthritis and related conditions. Br J Ophthalmol 1969;53:361-72.
5. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol 1965;4:187-97.
6. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 1965;4:198-205.
7. Foon KA, Yuen K, Ballintine EJ, Rosenstreich DL. Analysis of the systemic corticosteroid sensitivity of patients with primary open-angle glaucoma. Am J Ophthalmol 1977;83:167-73.
8. Clark AF. Steroids, ocular hypertension, and glaucoma. J Glaucoma 1995;4:354-69.
9. Becker B, Hahn KA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol 1964;57: 543-51.
10. Becker B. Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol 1971;1 (Pt 1):1-16.
11. Podos SM, Becker B, Morton WR. High myopia and primary open-angle glaucoma. Am J Ophthalmol 1966;62:1038-43.
12. Lewis JM, Priddy T, Judd J, et al. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. Am J Ophthalmol 1988;106:607-12.
13. Kitazawa Y, Horie T. The prognosis of corticosteroid-responsive individuals. Arch Ophthalmol 1981;99:819-23.
14. Armaly MF. The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 1966;75:32-5.
15. Armaly MF. Inheritance of dexamethasone hypertension and glaucoma. Arch Ophthalmol 1967;77:747-51.
16. Francois J, Heintz-de Bree CH, Tripathi RC. The cortisone test and the heredity of primary open-angle glaucoma. Am J Ophthalmol 1966;62:844-52.
17. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997; 275:668-70.
18. Wiggs JL, Allingham RR, Vollrath D, et al. Prevalence of mutations in TIGR/myocilin in patients with adult and juvenile primary open-angle glaucoma [letter]. Am J Hum Genet 1998;63:1549-52.
19. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene. N Engl J Med 1998;338:1022-7.
20. Johnson D, Gottanka J, Flugel C, et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997;115:375-83.
21. Kubota R, Kudoh J, Mashima Y, et al. Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A). Biochem Biophys Res Commun 1998;242:396-400.
22. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997;277:722-7.
23. Garbe E, Boivin JF, LeLorier J, Suissa S. Selection of controls in database case-control studies: glucocorticoids and the risk of glaucoma. J Clin Epidemiol 1998;51:129-35.
24. Dreyer EB. Inhaled steroid use and glaucoma [letter]. N Engl J Med 1993;329:1822.
25. Opatowsky I, Feldman RM, Gross R, Feldman ST. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995;102:177-9.
26. Samiy N, Walton DS, Dreyer EB. Inhaled steroids: effect on intraocular pressure in patients without glaucoma. Can J Ophthalmol 1996;31:120-3.
27. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337: 8-14.
28. Chylack LT Jr. Cataracts and inhaled corticosteroids [editorial]. N Engl J Med 1997;337:46-8.
29. Garbe E, Suissa S, LeLorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients. JAMA 1998;280:539-43.
30. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64.
31. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9.
32. Diggory P, Cassels-Brown A, Vail A, et al. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet 1995;345: 1604-6.
33. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994;112:69-73.
34. Wolfs RC, Klaver CC, Ramrattan RS, et al. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1640-5.